Gwyneth Paltrow to Exec Produce ‘Stand Up to Cancer’ TV Return – Again

Joel Gallen will co-exec produce the fourth event on Sept. 5

Sorry cancer: you don’t “stand” a chance.

The fourth “Stand Up to Cancer” event will air across ABC, CBS, Fox, NBC and 26 broadcast and cable networks on Friday, Sept. 5 at 8 p.m. ET.

The Entertainment Industry Foundation event has aired every two years since 2008; and it will once again be executive produced by Gwyneth Paltrow and president of Tenth Planet Productions Joel Gallen, along with the SU2C team.

Also read: Joan Lunden Diagnosed With Breast Cancer

Viewers will be able to interact with celebrities via social media and donate via a toll-free number, standuptocancer.org and text-to-give.

For the first time, there will be a Canadian co-broadcast of the telecast presenting Canada-specific content, which will air simultaneously on all four major English-language Canadian networks: CBC, City, CTV and Global.

“Cancer profoundly touched my life when I lost my father to the disease twelve years ago, and Stand Up To Cancer gives me a powerful platform to fight for a cause that I’m passionate about,” Paltrow said in a statement. “I am thrilled to join Joel Gallen to executive produce the ‘Stand Up To Cancer’ telecast again this year, and honored to continue standing up in my father’s memory.”

Also read: NY Times Editor Dean Baquet Reveals to Staff He Had Cancerous Tumor Removed

“When we launched Stand Up To Cancer, our goal was to approach the struggle against cancer in a different way. Just six years into this movement, the incredible generosity of our donors — of every level — has enabled major progress in developing new treatments,” said Katie Couric, a co-founder of SU2C. “This program offers a unique opportunity to share the story of our progress and to remind viewers that each and every individual can play a role in supporting these scientists and their tireless work on behalf of patients.”

The celebrity lineup for the 2014 telecast will be announced throughout the summer. To date, more than $261 million has been pledged to support SU2C’s innovative cancer research programs.

Comments